glp-1 supply expansion news today Drug Manufacturing: & Tech Transfer Pharma Giants Bet on Next-Generation
Description
Glick HA, Briggs AH, Polsky D
These medications have significantly improved pharmacokinetic profiles and are long-acting, requiring only weekly administration
Recently, administration of a long-acting GIP receptor agonist in humans, reduced GLP-1 analogue related gastrointestinal side effects, including nausea and vomiting (106)
Effect of bimagrumab vs placebo on body fat mass among adults with type 2 diabetes and obesity: A phase 2 randomized clinical trial
